|
HS Code |
597234 |
| chemical_name | meso-Hexestrol |
| cas_number | 84-16-2 |
| molecular_formula | C18H22O2 |
| molecular_weight | 270.37 |
| appearance | White crystalline powder |
| melting_point | 178-181°C |
| solubility | Soluble in ethanol and chloroform; sparingly soluble in water |
| synonyms | meso-3,4-Bis(4-hydroxyphenyl)hexane |
| pharmacological_class | Nonsteroidal estrogen |
| IUPAC_name | 4,4'-(hexane-2,4-diyl)diphenol |
| storage_conditions | Store in a cool, dry place, tightly closed |
As an accredited meso‑Hexestrol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for meso‑Hexestrol contains 5 grams of white crystalline powder, sealed in an amber glass bottle with detailed labeling. |
| Shipping | meso-Hexestrol is shipped in tightly sealed containers, protected from light and moisture. It is transported following standard regulations for chemicals, ensuring safety through temperature control if required. Packaging is clearly labeled with hazard information. All handling and transit comply with local and international chemical shipping guidelines to prevent spillage or contamination. |
| Storage | meso-Hexestrol should be stored in a tightly closed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers. Store at room temperature, typically between 15–25°C (59–77°F). Ensure proper labeling and secure from uncontrolled access. Always follow institutional and regulatory storage requirements for hazardous chemicals. |
Applications of meso‑Hexestrol in Industrial ManufacturingAs a direct manufacturer of meso‑hexestrol, we support multiple downstream industries with high-quality raw material suitable for stringent process integration. Below, we outline key industrial application scenarios based on real market demands and technical regulatory frameworks. 1. Pharmaceutical Intermediates for Synthetic Steroid ProductionIn the pharmaceutical sector, meso‑hexestrol serves as an intermediate for the synthesis of selective estrogen receptor modulators (SERMs) and certain steroidal hormones. Production lines rely on exact chemical conversions, especially for processes targeting active pharmaceutical ingredient (API) synthesis where molecular isomer purity directly impacts product safety profiles and clinical compliance. Downstream integrators implement GMP-compliant batch tracking from the point of raw material input to the final isolated compound, requiring full documentation of reaction yields and purification steps. Compliance with pharmacopoeial testing methods during QC stages ensures consistent batch release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Laboratory Reagent for Estrogenic Activity ResearchResearch institutions and biotech labs utilize meso‑hexestrol as a reference compound in estrogen receptor binding assays, endocrine disruptor studies, and toxicology evaluations. Its reproducible structure enables consistent assay standardization for both cell-based and animal model studies. Batch-to-batch purity and traceability are critical for peer-reviewed research and regulatory submission data. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Raw Material in Specialty Polymer Additive Synthesismeso‑Hexestrol is used as a comonomer or functionalizing agent in the synthesis of specialty polymers, where its phenolic groups impart enhanced stability and tailored interaction with matrix resins. In this segment, precise dosing controls antioxidant characteristics and long-chain structure modification in thermoplastic or thermoset systems. Manufacturers run closed-system addition, monitor for residual monomer removal, and enforce tight resin formulation reproducibility through inline spectrophotometric checks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Active Component in Veterinary Formulationsmeso‑Hexestrol, under veterinary drug regulations, is formulated as an active agent in hormone therapy for animal breeding cycles and reproductive management protocols, subject to tight controls and regional limitations. Veterinary formulations focus on controlled-release mechanisms, dose calibration per species, and withdrawal time precision. Only certified veterinary facilities with DEA or regional authority oversight can integrate this material, with supply chain and finished product batch records inspected during regulatory audits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive meso‑Hexestrol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At our manufacturing site, meso‑Hexestrol isn’t just another chemical compound rolling off the line. Its origins and every stage of production shape the final outcome in terms of purity, performance, and reliability. Years spent overseeing the process from reaction planning, isolation, crystallization, and final analysis have taught us that real quality comes from the sum of many interconnected steps done right, every single time.
The substance, meso‑Hexestrol, lands in the catalog as a synthetic, nonsteroidal estrogen. In terms of molecular structure, it is C18H22O2, often produced via reduction of hexestrol or related precursors. Through direct experience, meticulous control over reductions, work-ups, and purifications produces a material that not only meets lab-assay benchmarks but also behaves consistently in practical usage.
Specification-wise, our batches measure at a white to off-white crystalline solid, with purity above 99.5% as confirmed by HPLC and GC analysis. Water content hovers below 0.2% following careful drying, and melting points cluster between 182 and 185°C, which aligns well with reference samples prepared in parallel. Making each kilo of material means pulling analytical samples several times along the route to confirm absence of diastereomeric and impurity peaks, so every lot feels like a fingerprint.
Production doesn’t run on software and spreadsheets alone. In our experience, the temperature profile during hydrogenation, especially the choice of catalyst and solvent, influences both rate and selectivity. By documenting outcomes at each stage, we fine-tune every critical parameter, eventually securing a material free from unknown byproducts and off-odors—a sign that every valve and jacket functioned as designed.
meso‑Hexestrol first caught attention for its hormonal effects, finding a historic role within biochemical and endocrinological research. In laboratories, the compound often works as a reference standard for comparative binding assays or as a reagent in receptor studies. Years of direct collaborations with academic and pharmaceutical groups have left no doubts: reproducibility in these experiments relies heavily on the lot-to-lot integrity of the supplied material.
On the manufacturing side, applications drive how we scale. Some partners require only gram to multi-gram supplies for analytical purposes, while industry users can request multi-kilo campaigns. One large-scale run used in the synthesis of estrogenic analogues highlighted an operational truth: managing solvent systems and recycling protocols safeguards both yield and environmental impact. Our team drew up a procedure that recycled over 65% of solvent used, reducing waste and cost in equal measure.
Engagement with end-users goes deeper than taking orders. Early in our history, a research lab encountered discrepancies between different sources of meso‑Hexestrol—disparities that, on closer inspection, stemmed from both purity variations and trace byproducts carried over from incomplete reduction. By taking a direct look at their actual raw samples and mirroring their analytical procedures, we were able to trace the issue back to catalyst aging. Fresh catalyst batches immediately solved the reproducibility gap. Since then, every consignment includes a tailored analytical data set, mimicking customer protocols wherever possible.
Many in the industry overlook how critical minor impurities can be, especially when the compound interacts within cell-based or bioassay systems. Over the years, we’ve systematically segmented individual lots, employing NMR, mass spectrometry, and elemental analysis to guarantee transparency and confidence for those at the bench.
Comparison against other hexestrol isomers and nonsteroidal estrogens highlights the uniqueness of meso‑Hexestrol. Its trans-geometry gives distinct receptor affinities and bioactivity profiles versus, for instance, diethylstilbestrol or other positional isomers. Feedback from our clients, particularly in pharmacological screening, regularly points out that activity curves, receptor binding properties, and synthetic behavior can shift with minor configuration changes.
Historically, confusion sometimes arises when researchers or quality controllers conflate meso‑Hexestrol with its more discussed cousin, diethylstilbestrol (DES). Their names and structures may appear similar, but practical experience teaches that substitution on the backbone, steric influences, and even melting points differ enough to impact performance in the lab and beyond. We’ve tested this view consistently, watching how side reactions proceed in similar synthetic schemes and noticing clear divergences.
Several clients have commented that switching indiscriminately between these compounds often led to unexpected results—lost yield, impure intermediates, or altered biological readouts. By focusing on true-meso configuration, our product maintains the profile that researchers expect, rooted in uncontested analytical results and decades of side-by-side experimental work.
Control over critical parameters defines the difference between a reliable product and a problematic one. Over decades of batch production, direct observation rather than just theoretical checklists brings the clearest picture. For meso‑Hexestrol, particle size, polymorph distribution, and even packaging moisture content play quietly decisive roles in the compound’s downstream performance.
Some stories stick in our memory. In one particular lot, a minor equipment error led to a subtle moisture increase during the final storage phase. Only by routinely cross-referencing with long-term stability data did we catch a shift in melting point distribution. Immediate rectification followed, as well as a broader auditing step that now tracks storage room humidity with greater frequency and, at times, spot checks using Karl Fischer titration for every large lot. This vigilance, while time-consuming, heads off issues before they grow beyond minor headaches.
Production line operators, lab techs, and analytical chemists all bring their own critical skill sets. Our longest-serving technician still checks color and granulometry by eye before authorizing blending or final filling. This “feel” approach, backed up by instrument data, catches subtleties machines sometimes dismiss. Resulting material, once packed in high-barrier containers, ships only after triple-sealed and certified within our in-house analytical protocols.
Demand patterns change. One pivotal experience involved scaling up meso‑Hexestrol tenfold in response to a surge in requests from both contract research organizations and specialty pharmaceutical labs. Our process design, originally built for pilot-scale, required bold adaptation. Larger reactors, improved heat exchange surface areas, and altered batch quenching rates demanded hours of direct, boots-on-the-ground monitoring.
Missed details in these expansions can punish yield and even lead to specification drift. We found that doubling cooling rate shortened overall cycle time, yet threatened crystallite size if not timed perfectly with solvent composition adjustments. A close-knit team, well-versed in the process and in hands-on troubleshooting, steered us through such bottlenecks without compromising purity or homogeneity.
Raw material sourcing also tells a story. Fluctuations in reagent supply, especially for hydrogenation catalysts and high-purity solvents, forced us to establish redundancies and backup contracts. Where others cut corners, strict incoming inspection and traceability preserved reliability. Any supplier-related deviation in input quality typically surfaces as early-on as the pre-reaction step, where color or minor exotherms hint at unseen issues. Decades of pattern-recognition enable us to flag, segregate, and resolve these quickly, so no uncertainties pass down the line.
End-users, from bench scientists to process development teams, express nuanced requirements. Some pursue microgram levels for analytical spike-ins, others require kilogram-scale amounts for preclinical investigation. Through years of supply, repeated dialogue brought to light issues such as the effect of residual solvent on NMR baselines, packing density in automated weighing equipment, and the consequences of packaging materials on compound stability.
A feedback loop ensures that the next batch corrects for lessons learned in the last. A leading university group once found their assays confounded by static in their balance room, made worse by micro-particle clumping in one lot. This resulted in a subtle over-weighing effect that threw off final data sets. We switched to anti-static-coated bottles, included a brushed-aluminum liner, and verified these improvements hands-on in our own test weighing lab before the next shipment.
Transparency counts. We furnish detailed, batch-specific data for every shipment and provide annotated chromatograms, so researchers spot minute differences quickly. If analysis surfaces unexpected peaks, our analytical team holds channel-open dialogue to get to the bottom of discrepancies, not just shrug and move on. This hands-on approach, practiced through hundreds of shipments and corrective actions, has made all the difference in establishing long-term trust.
Today’s chemical manufacturing world demands more than just product compliance. All operations face growing scrutiny regarding waste output, solvent emissions, and energy consumption. Within our own facility, we design meso‑Hexestrol synthesis steps to minimize hazardous solvent use, preferring recycling processes when possible and thermal reclamation systems for solvent vapor capture.
Recently, one plant improvement project redirected waste steam from crystallization toward pre-heating incoming process water, saving over 10% on annual fuel input. Less obvious but equally important are process tweaks that reduce off-grade material. By extending reaction monitoring for slow-forming intermediates, we cut rework rates in half—meaning less chemical waste, fewer emissions, and lower overall costs.
In one case, we worked alongside an environmental auditor to quantify the lifecycle footprint of our meso‑Hexestrol program. Results underlined the benefits of upgrading to closed-loop wash systems, which, beyond regulatory compliance, drove direct operational savings. It showed that efficiency upgrades aren’t just a moral imperative—they pay off directly in reliability and margin.
Quality assurance remains foundational. Twenty years ago, most QC efforts focused on meeting internal benchmarks—these days, thoroughness at every step proves irreplaceable. We combine routine, automated HPLC/GC screens with classic wet chemistry, ensuring no single analytical strategy alone drives the decision process. The real value emerges from correlating bench-scale findings with final user applications and continuously closing the loop.
Occasionally, raw data contradicts expectations. In one instance, batches showed milky color on visual inspection, only to pass all spectroscopic tests. Delving deeper, we found trace carryover from earlier cleaning phases—a minute contaminant, but enough to be picked up by a discerning eye. After additional training with line staff, and a re-evaluation of washing protocols, the visual anomaly vanished in subsequent lots. These small course corrections form the backbone of a reliable supply chain.
Regulatory demands have become increasingly nuanced in recent years. Safety, storage, transport, and even minor residuals face routine questioning from both authorities and sophisticated buyers. Our documentation now includes not only compliance certificates but also the provenance of raw materials, analytical methods, and a recap of process validations. This willingness to dive into the details, not just file away paperwork, comes as a direct result of close work with auditing teams and frequent site visits by clients.
As global transport regulations shifted for select organic compounds, we implemented packaging and declaration improvements to bridge regulatory hurdles without delaying shipments. Active traceability, real-time status updates, and thorough export vetting have grown from contingency plans into daily habits.
Chemical products may seem interchangeable at first glance, yet subtle distinctions impact project outcomes. The journey from raw material selection to packaged product matters intensely for meso‑Hexestrol’s users, whether in the realm of scientific research or more advanced developmental chemistry. Over decades, close customer collaborations have shown that cutting corners or ignoring minor batch-to-batch consistency can launch whole investigative programs off course.
Some manufacturers pursue the appearance of standardization by publishing generic specifications, but our view has always been that practical differentiation emerges from field feedback, analytical nuance, and the daily experience of making the substance in real-world conditions. From analytical team members to operators and department heads, hands and eyes on the product lead to improvements that no automated report can predict.
Manufacturing meso‑Hexestrol continues to evolve with both technology and end-user expectation. The next phase of improvement lies in automation, tighter process control, and expanded analytical capability. Yet, amidst all the push for digital integration, human judgement and hands-on detective work remain irreplaceable. Steering large-lot campaigns through unplanned temperature spikes or shipment challenges often boils down to informed decision-making by experienced teams.
We’re not content to stand still. Every synthesis, every shipment, and every exchange with users frames the next generation of quality, reliability, and sustainability for meso‑Hexestrol. Building on the past, investing in lab and plant infrastructure, and fostering open communication ensures the highest levels of consistency and dependability for every user—whether they’re running a single batch reaction or pursuing cutting-edge scientific discovery.